Literature DB >> 21093993

Equine herpesvirus-1 infected peripheral blood mononuclear cell subpopulations during viremia.

S Wilsterman1, G Soboll-Hussey, D P Lunn, L V Ashton, R J Callan, S B Hussey, S Rao, L S Goehring.   

Abstract

Infection with equine herpesvirus-1 (EHV-1) causes respiratory disease, late term abortions and equine herpesvirus myeloencephalitis (EHM) and remains an important problem in horses worldwide. Despite increasing outbreaks of EHM in recent years, our understanding of EHM pathogenesis is still limited except for the knowledge that a cell-associated viremia in peripheral blood mononuclear cells (PBMCs) is a critical link between primary respiratory EHV-1 infection and secondary complications such as late-term abortion or EHM. To address this question our objective was to identify which PBMC subpopulation(s) are infected during viremia and may therefore play a role in transmitting the virus to the vascular endothelium of the spinal cord or pregnant uterus. PBMCs from 3 groups of animals were collected between days 4 and 9 following experimental infection with EHV-1 strain Findlay/OH03 or strain Ab4. PBMCs were labeled with primary antibodies selective for CD4+ or CD8+ T lymphocytes, B-lymphocytes, or monocytes and positively selected using magnetic bead separation. Cell numbers and EHV-1 genome numbers in each subpopulation were then determined using quantitative PCR for β-actin and the EHV-1 glycoprotein B, respectively. Viral genomic DNA was found in all PBMC subpopulations; the CD8+ lymphocytes were most frequently positive for viral DNA, followed by B-lymphocytes. These differences were statistically significant in horses infected with the EHV-1 strain Findlay/OH03, and ponies with Ab4. These results differ from what has been reported in in vitro studies, and indicate that different PBMC subpopulations may play different roles in EHV-1 viremia.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21093993     DOI: 10.1016/j.vetmic.2010.10.004

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  9 in total

1.  Oral Administration of Valganciclovir Reduces Clinical Signs, Virus Shedding and Cell-Associated Viremia in Ponies Experimentally Infected with the Equid Herpesvirus-1 C2254 Variant.

Authors:  Côme J Thieulent; Gabrielle Sutton; Marie-Pierre Toquet; Samuel Fremaux; Erika Hue; Christine Fortier; Alexis Pléau; Alain Deslis; Stéphane Abrioux; Edouard Guitton; Stéphane Pronost; Romain Paillot
Journal:  Pathogens       Date:  2022-05-04

2.  Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity.

Authors:  Christiane L Schnabel; Christine L Wimer; Gillian Perkins; Susanna Babasyan; Heather Freer; Christina Watts; Alicia Rollins; Nikolaus Osterrieder; Bettina Wagner
Journal:  BMC Vet Res       Date:  2018-08-22       Impact factor: 2.741

3.  Equine Herpesvirus 1 Bridles T Lymphocytes To Reach Its Target Organs.

Authors:  Katrien C K Poelaert; Jolien Van Cleemput; Kathlyn Laval; Herman W Favoreel; Liesbeth Couck; Wim Van den Broeck; Walid Azab; Hans J Nauwynck
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

4.  Failure to detect equid herpesvirus types 1 and 4 DNA in placentae and healthy new-born Thoroughbred foals.

Authors:  Lara J Brown; Geoff Brown; Julia Kydd; Tom A E Stout; Martin L Schulman
Journal:  J S Afr Vet Assoc       Date:  2019-05-30       Impact factor: 1.474

5.  Transcriptomic Profiling of Equine and Viral Genes in Peripheral Blood Mononuclear Cells in Horses during Equine Herpesvirus 1 Infection.

Authors:  Lila M Zarski; Patty Sue D Weber; Yao Lee; Gisela Soboll Hussey
Journal:  Pathogens       Date:  2021-01-07

6.  Equid herpesvirus-1 Distribution in Equine Lymphoid and Neural Tissues 70 Days Post Infection.

Authors:  Susanna Samoilowa; Kim S Giessler; Carlos E Medina Torres; Gisela Soboll Hussey; Allison Allum; Robert Fux; Christin Jerke; Matti Kiupel; Kaspar Matiasek; Dodd G Sledge; Lutz S Goehring
Journal:  Pathogens       Date:  2021-06-05

7.  Equine herpesvirus type 1 infection induces procoagulant activity in equine monocytes.

Authors:  Wee Ming Yeo; Nikolaus Osterrieder; Tracy Stokol
Journal:  Vet Res       Date:  2013-03-11       Impact factor: 3.683

8.  Subcutaneous Administration of Low-Molecular-Weight Heparin to Horses Inhibits Ex Vivo Equine Herpesvirus Type 1-Induced Platelet Activation.

Authors:  Tracy Stokol; Priscila B S Serpa; Marjory B Brooks; Thomas Divers; Sally Ness
Journal:  Front Vet Sci       Date:  2018-05-28

9.  Equine Herpesvirus Type 1 Modulates Cytokine and Chemokine Profiles of Mononuclear Cells for Efficient Dissemination to Target Organs.

Authors:  Selvaraj Pavulraj; Mohamed Kamel; Heike Stephanowitz; Fan Liu; Johanna Plendl; Nikolaus Osterrieder; Walid Azab
Journal:  Viruses       Date:  2020-09-08       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.